CD44 and familial pancreatic carcinoma: Chenwei Li’s team30 showed that cells that expressed CD44 (0.5–5%) and c-Met showed a capacity for self-renewal and had the highest tumorigenic potential of all cell populations studied in pancreatic cancer.